QLN

Extracorporeal System For Carbon Dioxide Removal For The Treatment Of Covid-19

产品代码
QLN
器械名称
Extracorporeal System For Carbon Dioxide Removal For The Treatment Of Covid-19
管理类别
第 N 类(Not Classified)
FDA 专业组
Unknown
上市路径
EUA - Emergency Use Authorization
标记
属生命支持/维持器械

FDA 分类定义

to treat lung failure due to COVID-19 when used as an adjunct to noninvasive or invasive mechanical ventilation in reducing hypercapnia and hypercapnic acidosis due to Coronavirus Disease 2019 (COVID-19), and/or maintaining normalized levels of partial pressure of carbon dioxide (PCO2) and pH in patients suffering from acute, reversible respiratory failure due to COVID-19 for whom ventilation of CO2 cannot be adequately, safely, or tolerably achieved.

定义原文来自 FDA 器械分类库,属美国联邦政府作品(公有领域)。

FDA 官方分类页: QLN
分类与上市路径以 FDA 现行公告为准。本页数据来自 openFDA(CC0 公有领域),不构成注册策略建议。